Cathie Wood says these 3 health stocks will be the backbone of $1 trillion opportunity

Catherine Wood, chief executive officer of ARK Investment Management LLC, speaks during the Milken Institute Global Conference in Beverly Hills, California, on Monday, Oct. 18, 2021.
Kyle Grillot | Bloomberg | Getty Images

Gene-editing stocks may have disappointed lately but Cathie Wood still sees them as a big opportunity for long-term investors, and highlighted three favorites.

More In Follow the Pros

CNBC ProBest trades on CNBC Tuesday: Pros pick their favorite energy names and compare retailer earnings
CNBC ProMaverick Capital increases bets on Carvana, Uber and Snowflake in the first quarter
CNBC ProViking Global builds on Amazon position, dumps FedEx and Tesla in active first quarter